thailandedition
Princess Chulabhorn Awards, Donates Cancer Drug to UHC Patients

Princess Chulabhorn Awards, Donates Cancer Drug to UHC Patients

MGR Online•General•18d ago

Reader Briefing

Princess Chulabhorn bestows the 'Sri Sawang Khongkham Award' and donates the cancer medication 'Imicranib 100' to patients covered by Thailand's Universal Health Coverage.

  • •Princess Chulabhorn presided over the 'Sri Sawang Khongkham Award' ceremony for healthcare units excelling in medical services.
  • •A donation of 690,000 tablets of 'Imicranib 100' cancer medication was made to the National Health Security Office (NHSO).
  • •The event took place on Thursday, May 7, 2026, at the College of Medicine, Chulabhorn Royal Academy.
  • •The donation is part of a program commemorating the Princess's 69th birthday and aims to improve access to modern cancer treatment.

Overview

  • •On Thursday, May 7, 2026, Princess Chulabhorn presided over the 'Sri Sawang Khongkham Award' ceremony.
  • •Princess Chulabhorn granted the 'Sri Sawang Khongkham Award' to healthcare units demonstrating excellence in medical services.
  • •Princess Chulabhorn donated 690,000 tablets of 'Imicranib 100' to the National Health Security Office (NHSO).
  • •The donation of 'Imicranib 100' is for cancer patients under the Universal Health Coverage system, in commemoration of the Princess's 69th birthday on July 4, 2026.
  • •The 'Imicranib 100' medication is a targeted cancer therapy, the first of its kind produced in Thailand.
  • •'Imicranib 100' was registered by the Food and Drug Administration on May 20, 2025, and included in the Thai Innovation list on March 30, 2026.
  • •The donation aims to provide access to modern treatment for Thai citizens, overcoming financial barriers and improving quality of life.
  • •Chulabhorn Royal Academy was established to be a pillar of national public health and advance medical science and pharmaceutical research.

Full article content is available on the original source.

Read on MGR Online (Thai Version)View in Google Translate

Source: MGR Online (Original)

View Original Article

Key Entities

Person

Princess Chulabhorn(กรมพระศรีสวางควัฒน)ℹ️
The presiding royal figure who granted awards and donated medication.
Professor Dr. Her Royal Highness Princess Chulabhorn(ศาสตราจารย์ ดร. สมเด็จพระเจ้าน้องนางเธอ เจ้าฟ้าจุฬาภรณวลัยลักษณ์ อัครราชกุมารี กรมพระศรีสวางควัฒน วรขัตติยราชนารี)ℹ️
The full royal title of the Princess, emphasizing her role as President and Chair of the Council of Chulabhorn Royal Academy.

Law

Imicranib 100(อิมครานิบ 100)
A type of targeted cancer medication, the first produced in Thailand, donated to cancer patients.
Universal Health Coverage(ระบบหลักประกันสุขภาพถ้วนหน้า)ℹ️
The public health insurance system under which cancer patients receive treatment and medication.

Organization

Chulabhorn Royal Academy(ราชวิทยาลัยจุฬาภรณ์)ℹ️
The institution where the award ceremony and donation took place, championing national public health and medical research.
National Health Security Office (NHSO)(สำนักงานหลักประกันสุขภาพแห่งชาติ (สปสช.))ℹ️
The body that received the donation of 'Imicranib 100' for distribution to cancer patients.

Place

College of Medicine, Sri Sawang Khongkham(วิทยาลัยแพทยศาสตร์ศรีสวางควัฒน)
The location within the Chulabhorn Royal Academy where the event was held.

Timeline

Thursday, May 7, 2026(วันพฤหัสบดีที่ 7 พฤษภาคม 2026)
The date when Princess Chulabhorn presided over the award ceremony and donated medication.
July 4, 2026(4 กรกฎาคม พ.ศ. 2026)
The Princess's birthday, on which occasion the donation of 'Imicranib 100' was decided.
2025 BE(พุทธศักราช 2025)
The year the 'Sri Sawang Khongkham Award' was presented for the year's excellence.
May 20, 2025(20 พฤษภาคม พ.ศ. 2025)
The date 'Imicranib 100' was registered by the Food and Drug Administration.
March 30, 2026(30 มีนาคม 2026)
The date 'Imicranib 100' was included in the Thai Innovation list.
2020(๒๕๖๓)
The year a pharmaceutical manufacturing plant within the Chulabhorn Royal Academy was established.